Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

NCT02646358 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of Vepoloxamer
Healthy Volunteers
Renal Impaired

Interventions

DRUG: Vepoloxamer

Sponsor

Mast Therapeutics, Inc.